Updated Oct. 27, 2023 4:03 am ET
Sanofi said it plans to spin off its consumer-healthcare business, making it the latest major drugmaker to sharpen its focus on prescription medicines.
The French pharmaceutical company outlined the plan on Friday as part of a strategic update that also detailed plans to increase investment in its drug-development pipeline and cut costs.
Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8